Steven L. Carroll

ORCID: 0000-0001-6714-4373
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neurofibromatosis and Schwannoma Cases
  • Neuroblastoma Research and Treatments
  • Nerve injury and regeneration
  • Alzheimer's disease research and treatments
  • Sarcoma Diagnosis and Treatment
  • HER2/EGFR in Cancer Research
  • Virus-based gene therapy research
  • Herpesvirus Infections and Treatments
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Glioma Diagnosis and Treatment
  • Axon Guidance and Neuronal Signaling
  • Genetic Associations and Epidemiology
  • Neuropeptides and Animal Physiology
  • Glycosylation and Glycoproteins Research
  • Monoclonal and Polyclonal Antibodies Research
  • Soft tissue tumors and treatment
  • Cell death mechanisms and regulation
  • Protein Degradation and Inhibitors
  • Hereditary Neurological Disorders
  • Neurogenesis and neuroplasticity mechanisms
  • Autophagy in Disease and Therapy
  • Parkinson's Disease Mechanisms and Treatments
  • Dementia and Cognitive Impairment Research
  • Soft tissue tumor case studies
  • Signaling Pathways in Disease

Medical University of South Carolina
2015-2024

MUSC Hollings Cancer Center
2023-2024

University of Alabama at Birmingham
2008-2021

Boston University
2017-2018

University of Miami
2017-2018

Framingham Heart Study
2018

Institute for Neurodegenerative Disorders
2018

The University of Texas Health Science Center at San Antonio
2018

Erasmus MC
2018

Johns Hopkins University
2016-2018

Vivianna M. Van Deerlin Patrick Sleiman Maria Martinez‐Lage Alice Chen‐Plotkin Li-San Wang and 95 more Neill R. Graff‐Radford Dennis W. Dickson Rosa Rademakers Bradley F. Boeve Murray Grossman Steven E. Arnold David Mann Stuart Pickering‐Brown Harro Seelaar Peter Heutink John C. van Swieten Jill R. Murrell Bernardino Ghetti Salvatore Spina Jordan Grafman John R. Hodges Maria Grazia Spillantini Sid Gilman Andrew P. Lieberman Jeffrey Kaye Randall L. Woltjer Eileen H. Bigio Marsel Mesulam Safa Al‐Sarraj Claire Troakes Roger N. Rosenberg Charles L. White Isidró Ferrer Albert Lladó Manuela Neumann Hans A. Kretzschmar Christine M. Hulette Kathleen A. Welsh‐Bohmer Bruce L. Miller Ainhoa Alzualde Adolfo López de Munain Ann C. McKee Marla Gearing Allan I. Levey James J. Lah John Hardy Jonathan D. Rohrer Tammaryn Lashley Ian R. Mackenzie Howard Feldman Ronald L. Hamilton Steven T. DeKosky Julie van der Zee Samir Kumar‐Singh Christine Van Broeckhoven Richard Mayeux Jean Paul Vonsattel Juan C. Troncoso Jillian J. Kril John B. Kwok Glenda M. Halliday Thomas D. Bird Paul G. Ince Pamela J. Shaw Nigel J. Cairns John C. Morris Catriona McLean Charles DeCarli William G. Ellis Stefanie H. Freeman Matthew P. Frosch John H. Growdon Daniel P. Perl Mary Sano David A. Bennett Julie A. Schneider Thomas G. Beach Eric M. Reiman Bryan K. Woodruff Jeffrey L. Cummings Harry V. Vinters Carol A. Miller Helena C. Chui Irina Alafuzoff Päivi Hartikainen Danielle Seilhean Douglas Galasko Eliezer Masliah Carl W. Cotman MJ Tuñón Mònica Martínez David G. Muñoz Steven L. Carroll Daniel Marson Peter Riederer Nenad Bogdanović Daniela Berg Håkon Håkonarson John Q. Trojanowski Virginia M.‐Y. Lee

10.1038/ng.536 article EN Nature Genetics 2010-02-14
Giovanni Coppola Subashchandrabose Chinnathambi Jason Ji Yong Lee Beth A. Dombroski Matt Baker and 95 more Alexandra I. Soto‐Ortolaza Suzee E. Lee Eric Klein Alden Huang Renee Sears Jessica Lane Anna M. Karydas Robert O. Kenet Jacek Biernat Li San Wang Carl W. Cotman Charles DeCarli Allan I. Levey John M. Ringman Mario F. Mendez Helena C. Chui Isabelle Le Ber Alexis Brice Michelle K. Lupton Elisavet Preza Simon Lovestone John Powell Neill R. Graff‐Radford Ronald Petersen Bradley F. Boeve Carol F. Lippa Eileen H. Bigio Ian R. Mackenzie Elizabeth Finger Andrew Kertesz Richard J. Caselli Marla Gearing Jorge L. Juncos Bernardino Ghetti Salvatore Spina Yvette Bordelon Wallace W. Tourtellotte Matthew P. Frosch Jean Paul Vonsattel Chris Zarow Thomas G. Beach Roger L. Albin Andrew P. Lieberman Virginia M. Lee John Q. Trojanowski Vivianna M. Van Deerlin Thomas D. Bird Douglas Galasko Eliezer Masliah Charles L. White Juan C. Troncoso Didier Hannequin Adam L. Boxer Michael D. Geschwind Satish Kumar Eva‐Maria Mandelkow Zbigniew K. Wszołek Ryan J. Uitti Dennis W. Dickson Jonathan L. Haines Richard Mayeux Margaret A. Pericak‐Vance Lindsay A. Farrer Liana G. Apostolova Steven E. Arnold Clinton T. Baldwin Robert C. Barber M. Michael Barmada Thomas G. Beach Gary W. Beecham Duane Beekly David A. Bennett Deborah Blacker James D. Bowen Adam Boxer James R. Burke Jacqueline L. Buros Joseph D. Buxbaum Nigel J. Cairns Laura B. Cantwell Chuanhai Cao Chris Carlson Regina M. Carney Minerva M. Carrasquillo Steven L. Carroll David G. Clark Jason J. Corneveaux Paul K. Crane Carlos Cruchaga Jeffrey L. Cummings Philip L. De Jager Charles DeCarli Steven T. DeKosky F. Yesim Demirci Ramon Diaz‐Arrastia

Rare mutations in the gene encoding for tau (MAPT, microtubule-associated protein tau) cause frontotemporal dementia-spectrum (FTD-s) disorders, including FTD, progressive supranuclear palsy (PSP) and corticobasal syndrome, a common extended haplotype spanning across MAPT locus is associated with increased risk of PSP Parkinson's disease.We identified rare variant (p.A152T) patient clinical diagnosis assessed its frequency multiple independent series patients neurodegenerative conditions...

10.1093/hmg/dds161 article EN Human Molecular Genetics 2012-05-03
Perry G. Ridge Kaitlyn B. Hoyt Kevin L. Boehme Shubhabrata Mukherjee Paul K. Crane and 95 more Jonathan L. Haines Richard Mayeux Lindsay A. Farrer Margaret A. Pericak‐Vance Gerard D. Schellenberg John S. K. Kauwe Perrie M. Adams Marilyn S. Albert Roger L. Albin Liana G. Apostolova Steven E. Arnold Sanjay Asthana Craig Atwood Clinton T. Baldwin Robert C. Barber M. Michael Barmada Lisa L. Barnes Sandra Barral Thomas G. Beach James T. Becker Gary W. Beecham Duane Beekly David A. Bennett Eileen H. Bigio Thomas D. Bird Deborah Blacker Bradley F. Boeve James D. Bowen Adam Boxer James R. Burke Jeffrey M. Burns Joseph D. Buxbaum Nigel J. Cairns Laura B. Cantwell Chuanhai Cao Chris Carlson Cynthia M. Carlsson Regina M. Carney Minerva M. Carrasquillo Steven L. Carroll Helena C. Chui David G. Clark Jason J. Corneveaux Paul K. Crane David H. Cribbs Elizabeth Crocco Carlos Cruchaga Philip L. De Jager Charles DeCarli F. Yesim Demirci Malcolm Dick Dennis W. Dickson Rachelle S. Doody Ranjan Duara Nilüfer Ertekin‐Taner Denis A. Evans Kelley Faber Thomas Fairchild Kenneth B. Fallon David W. Fardo Martin R. Farlow Steven H. Ferris Tatiana M. Foroud Matthew P. Frosch Douglas Galasko Marla Gearing Daniel H. Geschwind Bernardino Ghetti John R. Gilbert Alison Goate Neill R. Graff‐Radford Robert C. Green John H. Growdon Håkon Håkonarson Ronald L. Hamilton Kara L. Hamilton‐Nelson John Hardy Lindy E. Harrell Lawrence S. Honig Ryan Huebinger Matthew J. Huentelman Christine M. Hulette Bradley T. Hyman Gail P. Jarvik Gregory A. Jicha Lee‐Way Jin Gyungah Jun M. Ilyas Kamboh Anna Karydas Mindy J. Katz John S. K. Kauwe Jonathan Kaye Ronald Kim Neil W. Kowall Joel H. Kramer

Alzheimer's disease (AD) is a complex genetic disorder with no effective treatments. More than 20 common markers have been identified, which are associated AD. Recently, several rare variants identified in Amyloid Precursor Protein (APP), Triggering Receptor Expressed On Myeloid Cells 2 (TREM2) and Unc-5 Netrin C (UNC5C) that affect risk for Despite the many successes, architecture of AD remains unsolved. We used Genome-wide Complex Trait Analysis to (1) estimate phenotypic variance...

10.1016/j.neurobiolaging.2016.02.024 article EN cc-by-nc-nd Neurobiology of Aging 2016-03-03
Gyungah Jun Jaeyoon Chung Jesse Mez Robert C. Barber Gary W. Beecham and 95 more David A. Bennett Joseph D. Buxbaum Goldie S. Byrd Minerva M. Carrasquillo Paul K. Crane Carlos Cruchaga Philip L. De Jager Nilüfer Ertekin‐Taner Denis A. Evans M. Danielle Fallin Tatiana Foroud Robert P. Friedland Alison Goate Neill R. Graff‐Radford Hugh C. Hendrie Kathleen Hall Kara L. Hamilton‐Nelson Rivka Inzelberg M. Ilyas Kamboh John S. K. Kauwe Walter A. Kukull Brian W. Kunkle Ryozo Kuwano Eric B. Larson Mark W. Logue Jennifer J. Manly Eden R. Martin Thomas J. Montine Shubhabrata Mukherjee Adam C. Naj Eric M. Reiman Christiane Reitz Richard Sherva Peter St George‐Hyslop Timothy Thornton Steven G. Younkin Badri N. Vardarajan Li‐San Wang Jens R. Wendlund Ashley R. Winslow Perrie M. Adams Marilyn S. Albert Roger L. Albin Liana G. Apostolova Steven E. Arnold Sanjay Asthana Craig Atwood Michjael M Barmada Lisa L. Barnes Thomas G. Beach James T. Becker Eileen H. Bigio Thomas D. Bird Deborah Blacker Bradley F. Boeve James D. Bowen Adam Boxer James R. Burke Nigel J. Cairns Chuanhai Cao Chris Carlson Cynthia M. Carlsson Regina M. Carney Minerva M. Carrasquillo Steven L. Carroll Helena C. Chui David G. Clark Jason J. Corneveaux David H. Cribbs Elizabeth Crocco Carlos Cruchaga Philip L. De Jager Charles DeCarli Steven T. DeKosky F. Yesim Demirci Malcolm Dick Dennis W. Dickson Rachelle S. Doody Ranjan Duara Nilüfer Ertekin‐Taner Kelley Faber Thomas Fairchild Kenneth B. Fallon Martin R. Farlow Steven H. Ferris Matthew P. Frosch Douglas Galasko Marla Gearing Daniel H. Geschwind Bernardino Ghetti John R. Gilbert Jonathan D. Glass Neill R. Graff‐Radford Robert C. Green John H. Growdon

Genetic loci for Alzheimer's disease (AD) have been identified in whites of European ancestry, but the genetic architecture AD among other populations is less understood.We conducted a transethnic genome-wide association study (GWAS) late-onset Stage 1 sample including Ancestry, African-Americans, Japanese, and Israeli-Arabs assembled by Disease Genetics Consortium. Suggestive results from novel were followed up using summarized International Genomics Project GWAS dataset.Genome-wide...

10.1016/j.jalz.2016.12.012 article EN cc-by-nc-nd Alzheimer s & Dementia 2017-02-07

Schwann cell dedifferentiation and proliferation is a prerequisite to axonal regeneration in the injured peripheral nervous system. The neuregulin (NRG) family of growth differentiation factors may play particularly important role this process, because these axon-associated molecules are potent mitogens vitro. We have examined DNA synthesis expression NRGs their receptors, erbB membrane tyrosine kinases, rat sciatic nerve, sensory ganglia, spinal cord 0-30 d postaxotomy. Analysis NRG cDNAs...

10.1523/jneurosci.17-05-01642.1997 article EN cc-by-nc-sa Journal of Neuroscience 1997-03-01

All members of the neurotrophin family neuronal growth factors promote survival and neurite outgrowth dorsal root ganglion (DRG) neurons in vitro. The trk protooncogenes encodes receptors that are now thought to mediate biological effects neurotrophins. In order learn more about dependence DRG on neurotrophins vivo, we have studied mRNA expression developing DRGs embryonic postnatal rats. We show here expressed thoracic lumbar by day 13 (E13), which is only 24-48 hr after neurogenesis begins...

10.1523/jneurosci.13-09-04029.1993 article EN cc-by-nc-sa Journal of Neuroscience 1993-09-01

Abstract Introduction Individuals with Down syndrome (DS) exhibit Alzheimer's disease (AD) neuropathology and dementia early in life. Blood biomarkers of AD would be valuable, as non‐AD intellectual disabilities DS overlap clinically. We hypothesized that elevations amyloid β (Aβ) peptides phosphorylated‐tau neuronal exosomes may document preclinical AD. Methods neuropathogenic proteins Aβ 1–42 , P‐T181‐tau, P‐S396‐tau were quantified by enzyme‐linked immunosorbent assays extracts purified...

10.1016/j.jalz.2016.08.012 article EN Alzheimer s & Dementia 2016-10-15

To present the current terminology and natural history of neurofibromatosis 1 (NF1) cutaneous neurofibromas (cNF).NF1 experts from various research clinical backgrounds reviewed terms currently in use for cNF as well clinical, histologic, radiographic features these tumors using published unpublished data.Neurofibromas develop within nerves, soft tissue, skin. The primary distinction between other is that are limited to skin whereas may involve skin, but not There important cellular,...

10.1212/wnl.0000000000005792 article EN cc-by Neurology 2018-07-09
Holly N. Cukier Brian W. Kunkle Badri N. Vardarajan Sophie Rolati Kara L. Hamilton‐Nelson and 95 more Martin Kohli Patrice L. Whitehead Beth A. Dombroski Derek Van Booven Rosalyn Lang Derek M. Dykxhoorn Lindsay A. Farrer Michael L. Cuccaro Jeffery M. Vance John R. Gilbert Gary W. Beecham Eden R. Martin Regina M. Carney Richard Mayeux Gerard D. Schellenberg Goldie S. Byrd Jonathan L. Haines Margaret A. Pericak‐Vance Marilyn S. Albert Roger L. Albin Liana G. Apostolova Steven E. Arnold Sanjay Asthana Craig Atwood Clinton T. Baldwin M. Michael Barmada Lisa L. Barnes Sandra Barral Thomas G. Beach James T. Becker Gary W. Beecham Duane Beekly David A. Bennett Eileen H. Bigio Thomas D. Bird Deborah Blacker Bradley F. Boeve Adam Boxer James R. Burke Jeffrey M. Burns Joseph D. Buxbaum Goldie S. Byrd Guiqing Cai Nigel J. Cairns Laura B. Cantwell Chuanhai Cao Cynthia M. Carlsson Regina M. Carney Minerva M. Carrasquillo Steven L. Carroll Helena C. Chui David G. Clark David H. Cribbs Elizabeth Crocco Carlos Cruchaga Philip L. De Jager Charles DeCarli F. Yesim Demirci Malcolm Dick Dennis W. Dickson Ranjan Duara Nilüfer Ertekin‐Taner Denis A. Evans Kelley Faber M. Daniele Fallin Kenneth B. Fallon David W. Fardo Martin R. Farlow Lindsay A. Farrer Steven H. Ferris Tatiana Foroud Matthew P. Frosch Douglas Galasko Marla Gearing Daniel H. Geschwind Bernardino Ghetti John R. Gilbert Rodney C.P. Go Alison Goate Neill R. Graff‐Radford Robert C. Green Patrick Griffith John H. Growdon Jonathan L. Haines Håkon Håkonarson Ronald L. Hamilton Kara L. Hamilton‐Nelson Vahram Haroutunian Lindy E. Harrell Lawrence S. Honig Ryan Huebinger Christine M. Hulette Bradley T. Hyman Gregory A. Jicha Lee‐Way Jin

<h3>Objective:</h3> To identify a causative variant(s) that may contribute to Alzheimer disease (AD) in African Americans (AA) the <i>ATP-binding cassette, subfamily A</i> (<i>ABC1</i>), <i>member 7</i> (<i>ABCA7</i>) gene, known risk factor for late-onset AD. <h3>Methods:</h3> Custom capture sequencing was performed on ∼150 kb encompassing <i>ABCA7</i> 40 AA cases and 37 controls carrying allele (rs115550680). Association testing an deletion identified large data sets (discovery n = 1,068;...

10.1212/nxg.0000000000000079 article EN cc-by-nc-nd Neurology Genetics 2016-05-18

Individuals with Down syndrome (DS) have a partial or complete trisomy of chromosome 21, resulting in an increased risk for early-onset Alzheimer's disease (AD)-type dementia by early midlife. Despite ongoing clinical trials to treat late-onset AD, individuals DS are often excluded. Furthermore, timely diagnosis management is not available. Of the genetic causes people represent largest cohort. Currently, there knowledge gap regarding underlying neurobiological mechanisms DS-related AD...

10.1002/alz.13692 article EN cc-by Alzheimer s & Dementia 2024-01-25

Abstract The neuregulin (NRG) family of growth and differentiation factors their erbB receptors contribute importantly to the development nervous system, but distribution function in adult brain are poorly understood. present study showed that erbB2, erbB3, erbB4 transcripts protein distributed throughout all areas rat brain. These three were differentially expressed neurons glia. Some only a subset kinases, whereas other sequestered each these polypeptides into distinct cellular...

10.1002/cne.1127 article EN The Journal of Comparative Neurology 2001-03-20

Neuregulin-1 (NRG-1) regulates developmental neuronal survival and synaptogenesis, astrocytic differentiation, microglial activation. Given these NRG-1 actions, we hypothesized that the synaptic loss, gliosis, inflammation, death occurring in Alzheimer disease (AD) is associated with altered expression of its receptors (the erbB2, erbB3, erbB4 membrane tyrosine kinases). We examined distribution erbB kinases hippocampus AD patients cognitively normal controls transgenic mice coexpress...

10.1093/jnen/62.1.42 article EN Journal of Neuropathology & Experimental Neurology 2003-01-01

Herpes simplex virus type 1 (HSV-1) mutants lacking the γ134.5 neurovirulence loci are promising agents for treating malignant glioma. Arming oncolytic HSV-1 to express immunostimulatory genes may potentiate therapeutic efficacy. We have previously demonstrated improved preclinical efficacy, biodistribution, and safety of M002, a γ134.5-deleted engineered murine IL-12. Herein, we describe biodistribution M032, that expresses human IL-12 after intracerebral administration nonhuman primates,...

10.1089/humc.2013.201 article EN Human Gene Therapy Clinical Development 2014-03-01

Neuroinflammation is a key element of AD pathology and conceivably result disturbed resolution. Resolution inflammation an active process which strictly orchestrated following the acute inflammatory response after removal stimuli. Acute actively terminated by specialized pro-resolving mediators (SPMs) thereby promoting healing return to homeostasis. Failed resolution may contribute persistent neuroinflammation aggravate pathology. BLT1 (leukotriene B4 receptor) ChemR23 (chemerin receptor 23)...

10.1111/bpa.12812 article EN cc-by-nc-nd Brain Pathology 2020-01-08

Abstract The exact mechanisms leading to CNS inflammation and myelin destruction in multiple sclerosis its animal model, experimental allergic encephalomyelitis (EAE) remain equivocal. In both EAE, complement activation is thought play a pivotal role by recruiting inflammatory cells, increasing phagocytosis macrophages, exerting direct cytotoxic effects through the deposition of membrane attack complex on oligodendrocytes. Despite this assumption, attempts evaluate complement’s contribution...

10.4049/jimmunol.165.10.5867 article EN The Journal of Immunology 2000-11-15

Surface-active phospholipid-containing particles are traditionally considered to be the product of type II pneumocytes. We now demonstrate membrane-bound lamellar cytoplasmic organelles in adult and suckling rat enterocytes that densely reactive with phospholipid-staining reagents. These structures were seen basolateral space, within intercellular junctions, unraveling on lumenal surface, more abundant after fat feeding. Light scrapings intestinal mucosa washings contained these bodies, as...

10.1172/jci114306 article EN Journal of Clinical Investigation 1989-10-01

Tamoxifen is widely used to treat estrogen receptor-positive breast cancer. Recent findings that tamoxifen and its derivative 4-hydroxytamoxifen (OHT) can exert receptor-independent cytotoxic effects have prompted the initiation of clinical trials evaluate use in receptor-negative malignancies. For example, OHT malignant peripheral nerve sheath tumors (MPNST) where not involved. In this study, we gained insights into by studying how it kills MPNST cells. Although caspases were activated...

10.1158/0008-5472.can-12-3765 article EN Cancer Research 2013-05-31
Coming Soon ...